International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 8, Issue 2 (March-April 2026) Submit your research before last 3 days of April to publish your research paper in the issue of March-April.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 8 Issue 2
March-April 2026

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Glabridin from Glycyrrhizha glabra Linn. as multi-targeted therapeutic agent against Alzheimer’s disease: an in-silico study

Author(s) Mr. VIVEK T V
Country India
Abstract Alzheimer’s disease (AD) is a progressive neurodegenerative disease mainly occurring in old age adults. Its pathophysiology involves accumulation of tau protein in brain leading to the intracellular neurofibrillary tangles (NFTs) and amyloid β protein accumulation leads to extracellular amyloid β plaques in the central nervous system. Existing treatments for such neurodegenerative conditions do not slow-down disease progression, and this will cause an overwhelming future burden on our healthcare system and immense suffering for many more patients and their families. The current researches for developing potential drugs for the Alzheimer’s disease mainly focusing on the therapeutic targets such as acetylcholine esterase (AChE), Butrylcholine esterase (BuChE), β-site APP-cleaving enzyme1 (BACE1), Glycogen synthase kinase-3β (GSK3β) and Kelch-like ECH Associated Protein 1 (Keap1). To halt the progression of the disease, discovery of the molecules that potentially interferes with these therapeutic targets is paramount important. The ADMET property analysis showed that 5 flavonoid compounds from the plant Glycyrrhiza glabra Linn. were biologically active with drug-likeliness nature. The molecular docking and molecular dynamic simulation studies evidenced that among these phytochemicals glabridin can be a potential inhibitor of the Alzheimer’s therapeutic target proteins AChE, BuChE, BACE-1, GSK3β and Keap1. This may have a role in controlling the pathogenesis and thereby curing the disease. Further in vivo investigations is required to validate the compound as a new therapeutic agent for the Alzheimer’s disease.
Keywords Alzheimer's Disease, Glycyrrhiza glabra Linn., Glabridin, Therapeutic agent, In-silico study
Field Biology > Medical / Physiology
Published In Volume 7, Issue 5, September-October 2025
Published On 2025-10-02
DOI https://doi.org/10.36948/ijfmr.2025.v07i05.56650
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 8 Isu 2Cover Page Vol 8 Isu 1Cover Page Vol 7 Isu 6

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9687-828-838 editor@ijfmr.com
Powered by Sky Research Publication and Journals